CREBL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.774200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.857600E-01
Normal-vs-Stage2
7.001800E-02
Normal-vs-Stage3
1.321660E-02
Normal-vs-Stage4
1.640980E-01
Stage1-vs-Stage2
2.820800E-01
Stage1-vs-Stage3
7.112200E-02
Stage1-vs-Stage4
9.167400E-01
Stage2-vs-Stage3
1.651580E-01
Stage2-vs-Stage4
4.360200E-01
Stage3-vs-Stage4
1.378010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.809410E-01
Normal-vs-AfricanAmerican
4.440600E-01
Normal-vs-Asian
3.121700E-02
Caucasian-vs-AfricanAmerican
6.631200E-01
Caucasian-vs-Asian
1.052180E-01
AfricanAmerican-vs-Asian
1.814560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.953970E-01
Normal-vs-Female
1.671630E-01
Male-vs-Female
8.863000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.274600E-01
Normal-vs-Age(41-60Yrs)
3.632200E-01
Normal-vs-Age(61-80Yrs)
1.394040E-01
Normal-vs-Age(81-100Yrs)
3.581700E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.260200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.965800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.198400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.949810E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.304900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.501800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.843900E-03
Normal-vs-Daily Drinker
1.095710E-02
Normal-vs-Weekly Drinker
5.019600E-02
Normal-vs-Occasional Drinker
6.735200E-01
Normal-vs-Social Drinker
3.805600E-01
Non Drinker-vs-Daily Drinker
9.164800E-01
Non Drinker-vs-Weekly Drinker
7.806200E-01
Non Drinker-vs-Occasional Drinker
6.635800E-02
Non Drinker-vs-Social Drinker
1.101150E-01
Daily Drinker-vs-Weekly Drinker
7.325600E-01
Daily Drinker-vs-Occasional Drinker
6.331800E-02
Daily Drinker-vs-Social Drinker
1.044640E-01
Weekly Drinker-vs-Occasional Drinker
1.210190E-01
Weekly Drinker-vs-Social Drinker
2.168800E-01
Occasional Drinker-vs-Social Drinker
6.534200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.436000E-01
Normal-vs-Grade 2
1.037810E-01
Normal-vs-Grade 3
8.766400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.489380E-01
Grade 1-vs-Grade 3
2.122600E-01
Grade 1-vs-Grade 4
2.436000E-01
Grade 2-vs-Grade 3
7.204600E-01
Grade 2-vs-Grade 4
1.037810E-01
Grade 3-vs-Grade 4
8.766400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.424300E-02
Normal-vs-NonDiabetic
1.881760E-01
Diabetic-vs-NonDiabetic
6.602200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.786100E-02
Normal-vs-NoPancreatitis
1.936350E-01
Pancreatitis-vs-NoPancreatitis
4.092400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.585400E-01
Normal-vs-N1
7.405700E-02
N0-vs-N1
4.097000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.626300E-02
Normal-vs-TP53-NonMutant
5.572200E-01
TP53-Mutant-vs-TP53-NonMutant
1.700620E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
